<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Sarcomatoid Urothelial Carcinoma of the Urinary Bladder With Chondrosarcomatous and Concurrent Divergent Squamous Cell Carcinoma Differentiation- A Rare Entity.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Sarcomatoid Urothelial Carcinoma of the Urinary Bladder With Chondrosarcomatous and Concurrent Divergent Squamous Cell Carcinoma Differentiation- A Rare Entity." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884181/bin/cureus-0014-00000033107-i01.jpg"/> </div> <div class="text-side"> <h1>Sarcomatoid Urothelial Carcinoma of the Urinary Bladder With Chondrosarcomatous and Concurrent Divergent Squamous Cell Carcinoma Differentiation- A Rare Entity.</h1> <p>Histopathological images of the lesion after TURBT (Transurethral resection of bladder tumor)a) both squamous(arrow) and chondroid(arrowhead) elements (H&amp;EX40); b) sheets ofÂ chondrocytes (inset shows atypical chondrocytes in high power) (H&amp;EX200); c) squamous pearls admixed with central urothelial cells (line arrow) (H&amp;EX100); d &amp; e) Immunohistochemistry with CK7&amp;GATA 3 show positivity in overlying malignant epithelial cells (DABX40&amp;DABX200); f) IHC with S100 show positivity in chondrocytes (DABX200).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36721592/" target="_blank">36721592</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>